Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erhard Seifried

Showing results (151-160 of 189) with videos related to

Pageof 19
Sort By:
The Journal of Infectious Diseases|October 16, 2020
Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody TestingBernd Jahrsdörfer, Joris Kroschel, Carolin Ludwig, et al.
Stem Cells and Development|April 9, 2014
Identification and characterization of circulating variants of CXCL12 from human plasma: effects on chemotaxis and mobilization of hematopoietic stem and progenitor cellsRudolf Richter, Andrea Jochheim-Richter, Felicia Ciuculescu, et al.
Nature|February 7, 2004
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2Simone Rost, Andreas Fregin, Vytautas Ivaskevicius, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 13, 2021
Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent DonorsBernd Jahrsdörfer, Rüdiger Groß, Alina Seidel, et al.
Transfusion|September 17, 2016
Healthy donor hematopoietic stem cell mobilization with biosimilar granulocyte-colony-stimulating factor: safety, efficacy, and graft performancePetra Becker, Arnd Schwebig, Susanne Brauninger, et al.
Thrombosis and Haemostasis|August 21, 2024
A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, A Monoclonal Anti-HPA-1a Antibody for FNAIT PreventionChristof Geisen, Erika Fleck, Stephan Martin Gastón Schäfer, et al.
Plos Genetics|March 19, 2016
MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETONicole Kohrs, Stephan Kolodziej, Olga N Kuvardina, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 23, 2016
Pretransplant human leukocyte antigen antibodies detected by single-antigen bead assay are a risk factor for long-term kidney graft loss even in the absence of donor-specific antibodiesRudolf Richter, Caner Süsal, Stefanie Köhler, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept studyChristof Geisen, Mette Kjaer, Erika Fleck, et al.
European Journal of Immunology|April 7, 2022
SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccinationAndrea Jarisch, Eliza Wiercinska, Shabnam Daqiq-Mirdad, et al.
Pageof 19

Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
The Journal of Infectious Diseases|October 16, 2020
Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody TestingBernd Jahrsdörfer, Joris Kroschel, Carolin Ludwig, et al.
Stem Cells and Development|April 9, 2014
Identification and characterization of circulating variants of CXCL12 from human plasma: effects on chemotaxis and mobilization of hematopoietic stem and progenitor cellsRudolf Richter, Andrea Jochheim-Richter, Felicia Ciuculescu, et al.
Nature|February 7, 2004
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2Simone Rost, Andreas Fregin, Vytautas Ivaskevicius, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 13, 2021
Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent DonorsBernd Jahrsdörfer, Rüdiger Groß, Alina Seidel, et al.
Transfusion|September 17, 2016
Healthy donor hematopoietic stem cell mobilization with biosimilar granulocyte-colony-stimulating factor: safety, efficacy, and graft performancePetra Becker, Arnd Schwebig, Susanne Brauninger, et al.
Thrombosis and Haemostasis|August 21, 2024
A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, A Monoclonal Anti-HPA-1a Antibody for FNAIT PreventionChristof Geisen, Erika Fleck, Stephan Martin Gastón Schäfer, et al.
Plos Genetics|March 19, 2016
MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETONicole Kohrs, Stephan Kolodziej, Olga N Kuvardina, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 23, 2016
Pretransplant human leukocyte antigen antibodies detected by single-antigen bead assay are a risk factor for long-term kidney graft loss even in the absence of donor-specific antibodiesRudolf Richter, Caner Süsal, Stefanie Köhler, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept studyChristof Geisen, Mette Kjaer, Erika Fleck, et al.
European Journal of Immunology|April 7, 2022
SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccinationAndrea Jarisch, Eliza Wiercinska, Shabnam Daqiq-Mirdad, et al.
Pageof 19